by ADRIAN MANZ | Aug 18, 2025 | The Doctor's Dose
DeepSeek’s AI Model Delay and the Impact on Intraday Trading Opportunities China’s AI Ambitions Face Technical Headwinds The delay in the DeepSeek AI model underscores a significant challenge in Beijing’s push to reduce reliance on U.S. technology. The Chinese AI...
by ADRIAN MANZ | Aug 17, 2025 | The Doctor's Dose
Weight-Loss Drug Stocks and Day Trading Opportunities Pharma’s Former Darling Turns Volatile The meteoric rise of weight-loss drug stocks such as Novo Nordisk and Eli Lilly was once seen as a safe haven in the pharmaceutical sector. Fueled by the popularity of GLP-1...
by ADRIAN MANZ | Aug 15, 2025 | The Doctor's Dose
Big Tech AI Talent War: How Reverse Acquihires Could Reshape Silicon Valley The Big Tech AI talent war is pushing Microsoft, Meta, Google and others to pursue a new playbook—poach founders and core researchers, license the IP, and leave the startup shell behind. It’s...
by ADRIAN MANZ | Aug 14, 2025 | The Doctor's Dose
Disney and Marvel Leaving Georgia: Intraday Stock Action & What It Means for Cleveland What Happened (and Why It Matters) Reports indicate Disney’s Marvel is shifting most big-budget productions away from Georgia and toward the United Kingdom, citing a better...
by ADRIAN MANZ | Aug 13, 2025 | The Doctor's Dose
Trump’s Emerging Market Behavior: Is the US Beginning to Look Like Argentina? For decades, the United States has been the world’s benchmark for financial stability, transparency, and institutional independence. Yet in President Donald Trump’s second term, analysts and...
by ADRIAN MANZ | Aug 12, 2025 | The Doctor's Dose
Housing Market Correction Indicators: 3 Key Trends to Watch Despite appearing stagnant on the surface, the U.S. housing market is showing early signs of a potential shift—and possibly a correction. Economists are closely monitoring several key indicators to assess...
by ADRIAN MANZ | Aug 11, 2025 | The Doctor's Dose
Uber’s Autonomous Ambitions Spark Tesla Volatility: What Traders Need to Watch Shares of Uber Technologies (UBER) climbed in early trading Wednesday after the company posted strong second-quarter earnings, beat across key metrics, and unveiled a $20 billion share...
by ADRIAN MANZ | Aug 10, 2025 | The Doctor's Dose
Pfizer Raises Guidance Amid Drug Pricing Pressure: What Traders Should Know Pfizer (PFE) raised its full-year earnings guidance this week, signaling early success in its multibillion-dollar cost-cutting strategy while navigating political pressure from President...
by ADRIAN MANZ | Aug 9, 2025 | The Doctor's Dose
Teradyne Leads the S&P 500 After Strong Earnings and AI Momentum Teradyne (TER) shares surged Wednesday, topping the S&P 500 leaderboard after the company delivered solid second-quarter results and projected accelerating growth tied to artificial intelligence...
by ADRIAN MANZ | Aug 9, 2025 | The Doctor's Dose
Super Micro (SMCI) Slashes Guidance—And Still Misses the Mark for Wall Street Shares of Super Micro Computer Inc. (SMCI) plunged over 17% in premarket trading Wednesday after the company lowered its full-year revenue forecast and offered little reassurance on margins,...
